Mineralocorticoid deficiency and treatment in congenital adrenal hyperplasia
about
A highly sensitive method for the quantification of fludrocortisone in human plasma using ultra-high-performance liquid chromatography tandem mass spectrometry and its pharmacokinetic application.Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: A five-year retrospective study in the Children's Hospital of Damascus, Syria.Mineralocorticoid replacement during infancy for salt wasting congenital adrenal hyperplasia due to 21-hydroxylase deficiency.Mortality in children with classic congenital adrenal hyperplasia and 21-hydroxylase deficiency (CAH) in Germany.
P2860
Mineralocorticoid deficiency and treatment in congenital adrenal hyperplasia
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Mineralocorticoid deficiency and treatment in congenital adrenal hyperplasia
@en
type
label
Mineralocorticoid deficiency and treatment in congenital adrenal hyperplasia
@en
prefLabel
Mineralocorticoid deficiency and treatment in congenital adrenal hyperplasia
@en
P2860
P1476
Mineralocorticoid deficiency and treatment in congenital adrenal hyperplasia
@en
P2093
Peter C Hindmarsh
Raja Padidela
P2860
P304
P356
10.1186/1687-9856-2010-656925
P577
2010-05-04T00:00:00Z
P6179
1064133890